Literature DB >> 20395603

Dabigatran challenges warfarin's superiority for stroke prevention in atrial fibrillation.

Neil E Schwartz1, Gregory W Albers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20395603     DOI： 10.1161/STROKEAHA.110.584557

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  4 in total

Review 1.  Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.

Authors:  Alisa S Wolberg; Maria M Aleman; Karin Leiderman; Kellie R Machlus
Journal:  Anesth Analg       Date:  2011-11-21       Impact factor: 5.108

Review 2.  Stroke Prevention in Atrial Fibrillation.

Authors:  Michael Katsnelson; Sebastian Koch; Tatjana Rundek
Journal:  J Atr Fibrillation       Date:  2010-10-22

Review 3.  Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review.

Authors:  Luis Alcocer
Journal:  Am J Cardiovasc Drugs       Date:  2016-06       Impact factor: 3.571

4.  Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians.

Authors:  Stuart G Nicholls; Jamie C Brehaut; Rubab G Arim; Kelly Carroll; Richard Perez; Kaveh G Shojania; Jeremy M Grimshaw; Roy M Poses
Journal:  Thromb J       Date:  2014-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.